ARTICLE | Company News
Cephalon, MDS deal
January 13, 2003 8:00 AM UTC
CEPH will use MDS subsidiary MDS Proteomics Inc.’s differential analysis, chemiproteomics, PhosMap phosphorylation fingerprinting and protein interaction mapping technologies in its small molecule dev...